Sarepta | DuchenneXchange
Sarepta Corporate- Horizontal Logo (Full Color)
 

about

Sarepta Therapeutics is a leading precision genetic medicine company. We are primarily focused on rapidly advancing the development of our drug candidates for Duchenne muscular dystrophy (DMD) and other rare diseases.


Information and resources presented on this page were provided by our DuchenneXchange Industry sponsors.